Zurueck zur Suche

Reporte zur Charge CN3G5

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

43Reporte angezeigt
1Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
TX 6 TN 4 GA 4 IL 2 NC 2 NM 2 VA 2 OH 2 MI 2 IA 1 ID 1 NJ 1

VAERS 2608335

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

kritisch
Staat
IA
Alter
1,0
Geschlecht
M
Eingang
03.04.2023
Impfdatum
21.12.2022
Beginn
24.12.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
IM / LL
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Febrile convulsion

Symptomtext

Febrile seizure the following day. Died 3 days later of unknown causes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Recent febrile seizure the day after receiving vaccines.
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2515275

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

schwer
Staat
MN
Alter
17,0
Geschlecht
F
Eingang
23.11.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Pallor Syncope

Symptomtext

Approx 1015 am, immediately following 4th vaccine injection (mening) pt. became pale, swayed to the side and fainted. Nurse lowered her to the lfoor slowly, put legs up, by the time she was on the floor, she was awake. She had not eaten breakfast prior to appointment and stated later she has fainted before with vaccination (x1). This was not shared with nurse. Felt completely fine after juice and a snack (15 minutes).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
information regarding previous fainting unknown

VAERS 2480739

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

schwer
Staat
IL
Alter
7,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
05.10.2022
Beginn
08.10.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal X-ray Blood gases Chest X-ray Computerised tomogram Decreased appetite Endotracheal intubation Fatigue Full blood count Headache Hypotension Inflammatory marker test Intensive care Metabolic function test Nasal flaring Peripheral pulse decreased Pyrexia Rash Tachycardia

Symptomtext

Rash to face, neck, chest, abdomen, and extremities with fever prompting patient to be brought into the ED. Was also having decreased appetite, vomiting, headache, and fatigue. She was admitted to the floor on 10/10 for this. A rapid response was called on the patient on 10/12 due to hypotension, tachycardia, tachypnea, nasal flaring, decreased peripheral pulses, and decreased urine output. She was subsequently admitted to the PICU and is still being managed for this decompensation. She has required intubation and vasopressors for her condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
7,0
Labordaten
VBG, ABG, CBC, CMP, inflammatory markers, CXR, CT scans, XR abdomen, UA.
Aktuelle Erkrankungen
Otherwise Healthy
Vorgeschichte
Otherwise Healthy
Andere Medikamente
Tylenol 160 MG/5ML suspension, Flintstones Gummies, Benadryl 12.5 MG/5ML
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2469736

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge cn3g5

schwer
Staat
-
Alter
1,0
Geschlecht
M
Eingang
05.10.2022
Impfdatum
21.09.2022
Beginn
21.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Endotracheal intubation Generalised tonic-clonic seizure

Symptomtext

child had the vaccines in the morning before 12 noon , and had generalised tonic clonis seizure lasted for more than 20 minutes EMS was called by the parent child was taken to the ER where intubated to secure the airways in ER , Hospital course was 2 days ,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2415976

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

schwer
Staat
TX
Alter
13,0
Geschlecht
M
Eingang
19.08.2022
Impfdatum
19.08.2022
Beginn
19.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Dreamy state Syncope

Symptomtext

11:07, Right after administering HPV patient had an episode of syncope that lasted approx. 5 seconds. Pt states he felt as he was dreaming. Patient oriented X3 and was given cookies, juice, and candy. 11:29 states he felt fine and no longer felt faint.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2519965

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

moderat
Staat
-
Alter
1,1
Geschlecht
M
Eingang
30.11.2022
Impfdatum
01.11.2022
Beginn
03.11.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LG
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site pruritus Papule Pyrexia Tremor

Symptomtext

fevers with shaking (unlikely seizures based on description) followed by itching at site of injection and diffusely scattered papules

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
unknown, possible allergic reactions to nuts
Vorherige Impfungen
-

VAERS 2649644

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

mild
Staat
GA
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Extra dose administered Pain

Symptomtext

Seeming mild soreness; PedVaxHib was accidentally given in addition to Vaxelis, resulting in an extra dose of Hib vaccine; This case was retrieved during monitoring on 12-APR-2023 with the following Primary ID 2554760-1. The original narrative from the sender is as follows : Patient came in to get caught up on routine vaccines. PedVaxHib was accidentally given in addition to Vaxelis, resulting in an extra dose of Hib vaccine. No reaction noted at time of vaccination. Child tolerated vaccines well. Mom was contacted on 04-JAN-2023 to notify of extra dose and to ask how child was doing. Mom stated patient was doing well with no fever and seeming mild soreness. No concerns from mom other than to ask if child received all the vaccines he needed. The causal relationship between Vaxelis and the reported event Seeming mild soreness" was not provided. Due to the nature of the event, the causal relationship between Vaxelis and "PedVaxHib was accidentally given in addition to Vaxelis, resulting in an extra dose of Hib vaccine" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2554760

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

mild
Staat
GA
Alter
1,5
Geschlecht
M
Eingang
09.01.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Pain

Symptomtext

Patient came in to get caught up on routine vaccines. PedVaxHib was accidentally given in addition to Vaxelis, resulting in an extra dose of Hib vaccine. No reaction noted at time of vaccination. Child tolerated vaccines well. Mom was contacted on 1/4/2023 to notify of extra dose and to ask how child was doing. Mom stated patient was doing well with no fever and seeming mild soreness. No concerns from mom other than to ask if child received all the vaccines he needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2502600

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

mild
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
08.11.2022
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vomiting

Symptomtext

Patient threw up 1 time after receiving vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500742

MERCK & CO. INC. · HEP A (VAQTA) · Charge CN3G5

mild
Staat
NC
Alter
9,0
Geschlecht
M
Eingang
07.11.2022
Impfdatum
24.10.2022
Beginn
26.10.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash erythematous Vaccination site nodule

Symptomtext

Per mom , the child has red bumps all over body and a knot at site of right deltoid were vaccines given. Patient was seen by provider and per provider it may be varicella or MMR vaccine. Patient mom advise to use ice and NSAIDS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
n/a
Allergien
-
Vorherige Impfungen
-

VAERS 2481800

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

mild
Staat
IL
Alter
17,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Dizziness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
depression and anxiety
Andere Medikamente
Fluoxetine
Allergien
none known
Vorherige Impfungen
-

VAERS 2726668

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
NM
Alter
1,5
Geschlecht
M
Eingang
22.12.2023
Impfdatum
18.12.2023
Beginn
18.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Expired hepatitis A vaccine administered to patient. Plan to have patient return in 6 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NKA
Vorherige Impfungen
-

VAERS 2721520

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
MS
Alter
17,0
Geschlecht
M
Eingang
06.12.2023
Impfdatum
30.11.2023
Beginn
30.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently administered an expired Havrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received HAV (Havrix) (batch number CN3G5, expiry date 19-NOV-2023) for prophylaxis. On 30-NOV-2023, the patient received Havrix. On 30-NOV-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: inadvertently administered an expired Havrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 30-NOV-2023 A nurse called to inquire, how to proceed and reported they inadvertently administered an expired Havrix dose to a patient today on 30 November 2023 which led to expired vaccine used. The reporter did not consent to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649817

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
GA
Alter
2,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
11.05.2023
Beginn
11.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Kinrix vaccine given in error instead of DTAP. Error noted during monthly inventory county. Attempted to contact parent. Phone number no longer working. Alert put in child's chart.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None needed
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None Known
Allergien
None Known
Vorherige Impfungen
-

VAERS 2643505

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
IN
Alter
1,1
Geschlecht
F
Eingang
09.06.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

Patient is okay

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2639650

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
VA
Alter
15,0
Geschlecht
M
Eingang
01.06.2023
Impfdatum
13.12.2022
Beginn
13.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event

Symptomtext

In reviewing client's records for further immunizations, it was noted that the client's second Hep A was given too soon. He experienced no adverse events to the vaccine. I spoke with client's guardian to explain the situation and recommended that he be revaccinated. Client's guardian agreed and scheduled appointment for Hep A vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2624331

UNKNOWN MANUFACTURER · HEP A (NO BRAND NAME) · Charge CN3G5

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
01.05.2023
Impfdatum
22.02.2023
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 1-year-old patient who received Hepatitis A vaccine (batch number CN3G5) for prophylaxis. On 22-FEB-2023, the patient received the 2nd dose of Hepatitis A vaccine. On an unknown date, an unknown time after receiving Hepatitis A vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date: 14-Apr-2023. The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug. Sender's Comments: US-GSK-US2023054677: same reporter; US-GSK-US2023AMR055743: same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2624330

UNKNOWN MANUFACTURER · HEP A (NO BRAND NAME) · Charge CN3G5

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
01.05.2023
Impfdatum
10.01.2023
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 10-year-old patient who received Hepatitis A vaccine (batch number CN3G5) for prophylaxis. On 10-JAN-2023, the patient received the 2nd dose of Hepatitis A vaccine. On an unknown date, an unknown time after receiving Hepatitis A vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments: US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2623155

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge cn3g5

gering
Staat
-
Alter
1,1
Geschlecht
M
Eingang
28.04.2023
Impfdatum
01.02.2023
Beginn
01.02.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

vaccine given too soon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621520

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
ME
Alter
1,6
Geschlecht
F
Eingang
26.04.2023
Impfdatum
19.04.2023
Beginn
19.04.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Pentacel was given when DTaP was ordered. Provider, and parent notified. Patient suffered no adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2617946

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
19.04.2023
Impfdatum
11.04.2023
Beginn
11.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Vaccination error

Symptomtext

Patient received a third Havrix dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 4-year-old female patient who received HAV (Havrix) (batch number CN3G5, expiry date 19-NOV-2023) for prophylaxis. On 11-APR-2023, the patient received the 3rd dose of Havrix. On 11-APR-2023, an unknown time after receiving Havrix, the patient experienced extra dose administered (Verbatim: Patient received a third Havrix dose). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 18-MAR-2023 The reporter reported that by mistakenly patient received third dose of Havrix vaccine. The reporter wanted to know safety information regarding this situation. The reporter stated that the patient also received an extra dose of hepatitis B vaccine from Merck. The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up. The patient received extra dose of Havrix vaccine in error, which led to extra dose administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2582721

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
MT
Alter
1,0
Geschlecht
M
Eingang
15.02.2023
Impfdatum
01.02.2023
Beginn
15.02.2023
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Grabbed MMRV out of freezer instead of just MMR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2562230

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
KS
Alter
2,0
Geschlecht
F
Eingang
18.01.2023
Impfdatum
17.01.2023
Beginn
17.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered at inappropriate site Wrong product administered

Symptomtext

Incorrect vaccine given for primary series and incorrect site. No reports of adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2553037

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
07.01.2023
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia

Symptomtext

Patient received routine vaccines listed above. Patient complained of feeling weak. Patient assessed by RN. Patient vitals checked. P- 88, O2 SAT- 98%, BP- 110/72 R-20. Patient assisted to the floor. Patient legs elevated. Patient states feeling better. Patient assisted back to chair. Offered to call EMS for patient. Patient and family member refused. Patient monitored for 30 minutes. Follow up post vaccination instructions from system? drink, monitor self, report any lingering physical complaints to own provider. Instruction given regarding calling 911 or going to local emergency room for emergency symptoms. Translation provided. Patient and family verbalized understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Asthenia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2546295

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
GA
Alter
0,3
Geschlecht
F
Eingang
30.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

4 months old received Havrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received HAV (Havrix) (batch number CN3G5, expiry date 19th November 2023) for prophylaxis. On 19th December 2022, the patient received Havrix. On 19th December 2022, unknown after receiving Havrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional Information: GSK receipt date: 19-Dec-2022 Reporter's comment: The office manager called in to report that a Havrix dose was given to a patient under the recommended age for the Havrix vaccine. The vaccine was administered at the same location from where it was reported. The patient's information was collected. The vaccine administration facility was the same as primary reporter. The case was escalated to second line. The reporter consented to follow up. Additional supportive information: The patient received a dose of Havrix at inappropriate age, which led to inappropriate age at vaccine administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2535134

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TN
Alter
1,4
Geschlecht
M
Eingang
16.12.2022
Impfdatum
15.12.2022
Beginn
15.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Nurse was completing a child health immunization visit. Child was needing the Dtap, HIB, & Prevnar 13 today; Mother had declined the Flu & Covid-19 vaccines. I had my sticky note with the vaccines written on there that the child needed, & I'm unsure as to why I pulled a Hep A vaccine to administer instead of the HIB. I checked my 3 vaccines in hand 2-3 times of the expiration date, etc., but it never dawned on me that I didn't have the HIB in my hand. I came into the clinic room & had the child to get prepped to receive the vaccines in the legs; the vaccines had been scanned in system, & no warning box was provided to alert me that Hep A was up to date; only a pop-up box for no allergy assessment. I later called the mother to inform her of the occurrence of what had happened after I realized later that afternoon what I had done & she verbalized understanding & reports no issues with the child at this time, I informed her that this Hep A dose would be considered invalid & that he would need another dose at the appropriate interval in 3 months or so. I told the mother that he would need to have another appt. scheduled to receive the HIB vaccine & she states she will call back in 1 week or so for child to receive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2515742

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
NM
Alter
7,0
Geschlecht
F
Eingang
24.11.2022
Impfdatum
26.09.2022
Beginn
26.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Provider ordered DTAP and pt is 7 years old. DTAP can only be under age 7. MA administered DTAP. Re educated MA about age indications. Handouts given on vaccine age limits. Provider also informed

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2501389

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
WA
Alter
1,0
Geschlecht
F
Eingang
07.11.2022
Impfdatum
07.11.2022
Beginn
07.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

While drawing up the vaccine patient, intended to give 1 Varicella and 1 MMR. Instead, she was given 1 Varicella and 1 Proquad. The patient's parent was called after the MA consulted with MD. It was determined that the patient should not have any adverse effects after data was researched.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Runny nose and congestion
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2495160

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
MI
Alter
0,3
Geschlecht
M
Eingang
01.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administration error

Symptomtext

Patient received a pediatric dose of Hepatitis A in error. Did not discover until patient had left office. Patient left office in normal, stable condition. Spoke to PCP about this error who assured me that the patient would be okay. Called mother to let her know of mistake and explain that it was given in error, but there should be no adverse reactions..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2491951

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
NC
Alter
0,2
Geschlecht
F
Eingang
28.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

administered Havrix to a "4 days away from 3 months old pt"; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received HAV (Havrix) (batch number CN3G5, expiry date 19th November 2023) for prophylaxis. On 20th October 2022, the patient received the 1st dose of Havrix. On 20th October 2022, unknown after receiving Havrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional Information: GSK receipt date: 20-Oct-2022 Reporter's comment: No other information was provided. No additional adverse event or product quality complaint was reported. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The medical assistant was accidently administered Havrix on the day of reporting to a patient, which led to inappropriate age at vaccine administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2490996

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
VA
Alter
11,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered

Symptomtext

Nurse gave 5-1 BIV as primary series as current recommendation states 5-11 BIV for booster dose only. Patient observed for 15 min post exposure. Discharged WNL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2488392

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TX
Alter
6,0
Geschlecht
M
Eingang
25.10.2022
Impfdatum
17.09.2022
Beginn
17.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient Parent indicated on information form that patient was 7 years old when in actuality patient was 6 years and 8 months old. Patient received TDap instead of Dtap.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NoNE
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2480836

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
CA
Alter
1,3
Geschlecht
F
Eingang
17.10.2022
Impfdatum
21.09.2022
Beginn
21.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

patient had no Symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2477213

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
WI
Alter
16,0
Geschlecht
M
Eingang
13.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Client received MMR but did not need this vaccine. Foreign record of MMR given was not transcribed to state immunization registry prior to client's appointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none noted
Andere Medikamente
unknown
Allergien
none noted
Vorherige Impfungen
-

VAERS 2466667

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
NJ
Alter
5,0
Geschlecht
M
Eingang
01.10.2022
Impfdatum
21.09.2022
Beginn
21.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

A temperature excursion occurred 9/21/22 for 1 hour 38 minutes. Unknown at the time the IPOL vaccine was given. The IPOL was claimed as non viable and to be discarded. Family was notified and patient hasn't had any reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2454810

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TX
Alter
5,0
Geschlecht
F
Eingang
22.09.2022
Impfdatum
22.09.2022
Beginn
22.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

None at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None ordered
Aktuelle Erkrankungen
None
Vorgeschichte
None, unacompanied minor arrived initially at facility on 9/19/2022 (same day)
Andere Medikamente
Ibuprofen, Acetaminophen, Hydrocortisone and Congestion Tablet
Allergien
No allergies
Vorherige Impfungen
-

VAERS 2452227

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
ID
Alter
4,0
Geschlecht
F
Eingang
20.09.2022
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

Administered a proquad in addition to a varicella vaccine. Due to patient moving a partial dose of varicella was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2452078

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
MI
Alter
3,0
Geschlecht
M
Eingang
20.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Tdap given to patient outside the recommended age range

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2450907

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge cn3g5

gering
Staat
TN
Alter
1,5
Geschlecht
M
Eingang
19.09.2022
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation error

Symptomtext

patient received undiluted dose of pfizer for 6m-4y. No reported adverse reactions as of today

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2445017

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TN
Alter
1,6
Geschlecht
F
Eingang
14.09.2022
Impfdatum
14.09.2022
Beginn
14.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Expired product administered

Symptomtext

Pentacel Vaccine Lot # UJ571AAA Exp. date 09112011 was give by RN. He scanned Pentacel vaccine in system, administered vaccine, and attempted to put administration documentation and it would not pull vaccine with lot # and he realized he did not check expiration prior to administration and had administered an expired vaccine. LPN who manages vaccine inventory had Pentacel written on Monthly Expiration Date calendar and also on calendar at desk with other vaccine that was due to expire 09092022. She checks this calendar daily for vaccines that are due to expire and removes them. She removed other vaccine from vaccine refrigerator on 09092022 but failed to remove the Pentacel vaccine on 09092011 that expired 09112022. She put a check mark by vaccines on Monthly Expiration Date calendar and desk calendar indicating both had been removed. They immediately came to Nursing Supervisor and notified her of error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2441011

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
CT
Alter
9,0
Geschlecht
F
Eingang
12.09.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered

Symptomtext

0.2ml of undiluted covid19 pfizer 5-11 administered, no symptoms/signs to date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Undiluted Covid19 pfizer 5-11 vaccine administration. 0.2ml
Allergien
none
Vorherige Impfungen
-

VAERS 2439701

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TX
Alter
15,0
Geschlecht
M
Eingang
10.09.2022
Impfdatum
26.08.2022
Beginn
26.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No reported adverse event. 2nd COVID vaccine from primary series was given on day 15 instead of waiting for 21 days as recommended by guidelines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Non reported
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2421044

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge CN3G5

gering
Staat
TN
Alter
16,0
Geschlecht
F
Eingang
26.08.2022
Impfdatum
26.08.2022
Beginn
26.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Vaccination error Wrong product administered

Symptomtext

Administered Hepatitis A vaccine instead of HPV vaccine. Patient and patient mother notified of vaccine error, both voiced understanding. Patient remained in clinic 30 minutes post vaccine administration without adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
COVID-19 infection 7/2022, per patient mother.
Vorgeschichte
none
Andere Medikamente
Tri-Sprintec OCP one daily, prescribed by outside provider
Allergien
None
Vorherige Impfungen
-